Man

Craig Anderson

Executive Director

The George Institute for Global Health, China

Beijing, China

Líneas de Investigación


Investigador con gran experiencia en estudios epidemiológicos y ensayos clínicos académicos e internacionales, principalmente en áreas de la neurología (ataque cerebrovascular), con gran impacto a nivel internacional y publicaciones relevantes.

Educación

  •  Doctor of Philosophy, University of Western Australia. Australia, 1996
  •  Master in Public Health, University of Western Australia. Chile, 1991
  •  Bachelor of Medical Science, University of Tasmania. Chile, 1979
  •  Bachelor of Medicine and Surgey, University of Tasmania. Australia, 1982

Experiencia Académica

  •   Neurologist Part Time

    Royal Prince Alfred Hospital

    Medicine

    Sydney, Australia

    2010 - 2016

  •   Executive Director Full Time

    The George Institute for Global Health Beijing

    Peking University Heath Science Centre

    Beijing, China

    2014 - A la fecha

  •   Director Stroke and Mrain Health Program Part Time

    The George Institute for Global Health

    Sydney, Australia

    2010 - 2016

  •   Profesor Visitante Other

    Universidad del Desarrolllo

    Facultad de Medicina

    Santiago, Chile

    2018 - A la fecha

  •   Senior Principal Research Fellow Part Time

    National Health and Medical Research Council of Australia

    Australia

    2008 - 2009

  •   Honorary Professor Part Time

    Universidad de Sydney

    Sydney Medical School

    Sydney, Australia

    2010 - A la fecha

  •   Professor of Neurology and Epidemiology Part Time

    Universidad de NSW

    Medicine

    Chile

    2010 - 2016

Premios y Distinciones

  •   Finalist ACTA Trial of the Year

    Australian Clinical Trials Alliance

    Australia, 2017

    ACTA Sting Excellence in Trial Statistics Award: The Sleep Apnea in Cardiovascular Events Study (SAVE)

  •   Excellence in Stroke Award

    Stroke Society of Australasia

    Chile, 2015

    Excellence in Stroke Award

  •   Distinguished Professiorial Achievement Award

    UNIVERSITY OF SYDNEY

    Australia, 2013

    Distinguished Professorial Achievement Award- Sydney Medical School

  •   Impact Award on Research, Practice and Health

    The George Institte for Global Health

    Chile, 2013

    Impact Award on Research, Practice and Health


 

Article (19)

Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study
Prescription of antihypertensive medication at discharge influences survival following stroke
Quality of Life Is Poorer for Patients With Stroke Who Require an Interpreter: An Observational Australian Registry Study
Return to driving after a diagnosis of epilepsy: A prospective registry study
Stroke Incidence by Major Pathological Type and Ischemic Subtypes in the Auckland Regional Community Stroke Studies Changes Between 2002 and 2011
Association of body mass index with mortality and functional outcome after acute ischemic stroke
Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke
Discrepant relationships between admission blood pressure and mortality in different stroke subtypes
Frequency, determinants, and effects of early seizures after thrombolysis for acute ischemic stroke The ENCHANTED trial
Head Positioning in Acute Stroke
Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
Intensive Blood Pressure Lowering in Intracerebral Hemorrhage
Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke Secondary Analysis of the ENCHANTED Randomized Clinical Trial
Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time
Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies
Early blood pressure lowering in patients with intracerebral haemorrhage and prior use of antithrombotic agents: pooled analysis of the INTERACT studies
Regional variation in acute stroke care organisation
Statistical analysis plan for the second INTEnsive blood pressure Reduction in Acute Cerebral hemorrhage Trial (INTERACT2): a large-scale investigation to solve longstanding controversy over the most appropriate management of elevated blood pressure in the hyperacute phase of intracerebral hemorrhage
Field Environmental Philosophy and Biocultural Conservation: The Omora Ethnobotanical Park Educational Program

Abstract (14)

HEAD POSITION IN STROKE TRIAL: PROGRESS AND BASELINE CHARACTERISTICS
Significance of Cerebral Small Vessel Disease in Acute Intracerebral Hemorrhage: The INTERACT2 Study
Head Position in Stroke Trial (HeadPoST): Challenges of setting up of a large international stroke nursing care trial
Impact of haematoma shape and density on 90-day outcome after intracerebral haemorrhage: The INTERACT2 study
Influence of mannitol in acute intracerebral haemorrhage: Multivariate and propensity score analyses of INTERACT2
Rapid blood pressure lowering according to recovery at different time intervals after acute intracerebral hemorrhage: Pooled analysis of the interact studies
Workshop for Studies in Development Effects of mannitol on the clinical outcomes in acute intracerebral hemorrhage: Analysis in INTERACT2
Challenges to establishing a global clinical trial of stroke nursing care: Experience of the head position in acute stroke trial (HeadPoST)
Mechanisms of effect of early intensive BP lowering treatment: Pooled analysis of INTERACT CT substudies
Safety of prophylactic heparin in acute intracerebral haemorrhage: Post-hoc analysis of the INTERACT2 study
Significance of intraventricular haemorrhage in acute intracerebral haemorrhage: INTERACT2 results
Rationale of the Head Position in Acute Stroke Trial (HeadPoST)
The Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED): Complexity of Set-Up Large International Clinical Trial
The Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED): First Year Experience Regarding Possible Selection Bias
33
Craig Anderson

Executive Director

The George Institute for Global Health, China

Beijing, China

16
Craig Anderson

Executive Director

The George Institute for Global Health

Beijing, China

13
Pablo Lavados

Jefe

Departamento Científico Docente

Clínica Alemana de Santiago

Santiago, Chile

4
Paula Muñoz

Clinical Research Center Director

Universidad del Desarrollo

Santiago, Chile

2
Verónica Olavarria

Neurologa

Neurología y Psqiquiatría

Clinica Alemana de Santiago

Santiago, Chile

2
Rodrigo Rivas

Médico jefe

Servicio Medicina Física y Rehabilitación

Clínica Alemana Temuco

Temuco, Chile

1
Ricardo Rozzi

Professor

Philosophy & Religion

University of North Texas

Denton, Estados Unidos

1
Christopher Anderson

Scientist

Austral Center for Scientific Research

National Scientific and Technical Research Council

Ushuaia, Argentina